Kala Pharmaceuticals, a developer of products that effectively penetrate the mucosal barrier to treat various debilitating diseases, has received $11.5m in Series A equity financing round, led by new and existing investors. Kala said ...
Sky Ridge Medical Center in Colorado, US, has initiated the FDA-approved Delcath Systems' expanded access program (EAP) to provide US patients access to second-generation hemofiltration cartridge of Delcath's proprietary chemosaturation ...
Tags: Sky Ridge Medical Cente, US, FDA, Delcath Systems, EAP
InSite Vision has launched a new DuraSite 2 drug delivery system, designed to deliver ophthalmic therapeutics. DuraSite 2, which is based on InSite DuraSite technology, incorporates cataract surgery drug, ketorolac, a non-steroidal ...
Tags: InSite, Ophthalmic Drug Delivery System, ophthalmic therapeutics
Allergan and Molecular Partners have expanded their existing relationship by entering into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin products to treat ophthalmic diseases. The first ...
BioTime has signed an exclusive sublicense agreement and a supply agreement with Jade Therapeutics for ophthalmological drug delivery applications of HyStem technology. According to the agreement, BioTime will provide Jade with ...
Tags: HyStem technology, Biotime, Jade Therapeutics, ophthalmological drug
Drug delivery CRO Particle Sciences has developed a new ocular formulation leveraging its proprietary polymer for Eyeon Therapeutics. The polymer used in the development of the new formulation demonstrated significant results compared to ...
Tags: Proprietary Polymer, Particle Sciences, New Ocular Formulation
The USFDA has approved ThromboGenics'Jetrea(ocriplasmin)for the treatment of symptomatic vitreomacular adhesion(VMA). The approval was based on the Phase III trial data which demonstrated that Jetrea is superior to placebo for the ...
Tags: ThromboGenics'Jetrea, symptomatic vitreomacular adhesion, USFDA
Alcon, a provider of eye care products, has agreed to buy SensoMotoric Instruments' ophthalmic division. SensoMotoric's ophthalmic division products include ocular surgical guidance technology which provides real-time eye tracking, ...
Tags: Alcon, eye care products, ophthalmic division, cataract surgery
The Scottish Medicines Consortium (SMC) has approved the use of Alcon's Nevanac in patients suffering from diabetes to minimize the possibility of postoperative macular oedema (MO) coupled with cataract surgery. The approval allows the ...
Tags: The Scottish Medicines Consortium, diabetic cataract patients, Medicine
Orthofix International, a developer of repair and regenerative products, has launched a natural physiologic wound covering for use in both spinal and orthopedic applications. The wound covering VersaShield, which is processed from ...
Genentech, a member of Roche Group, has obtained clearance for its Lucentis 0.3 mg (ranibizumab injection) from the US Food and Drug Administration (FDA). Lucentis 0.3 mg is a recombinant humanized monoclonal antibody fragment (lacking an ...
Tags: Genentech, Lucentis 0.3 mg, Medicine, Injection
LED Engin, Inc., a leader in high lumen density LED products, announced three key appointments to support the company’s continuing rapid growth. The company has named Geoff Brown as VP of Sales; Jack S. Yeh as Vice President of Sales, ...
Tags: LED light
Stanford retinal implant combats vision loss 21 May 2012 An implanted subretinal array could restore useful sight to patients blinded by degenerative retinal diseases. A simpler system One characteristic of retinal conditions such as ...
Sunovion Pharmaceuticals is set to launch Zetonna (ciclesonide) nasal aerosol, a non-aqueous, dry nasal aerosol spray for allergic rhinitis in the third quarter of 2012 in the US. The 74mcg once-daily product is indicated for the ...
Tags: Sunovion Pharmaceuticals, Medicine, Zetonna nasal aerosol